SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

TILT Biotherapeutics Presents Phase 1b Ovarian Cancer Results at ESMO

Valid market news retained in the public archive without immediate LiveCast distribution.

Related stories